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Abstract. Isothermal rebreathing has been proposed as an experimental technique
for estimating the alveolar levels of hydrophilic volatile organic compounds (VOCs)
in exhaled breath. Using the prototypic test compounds acetone and methanol we
demonstrate that the end-tidal breath profiles of such substances during isothermal
rebreathing show a characteristic increase that contradicts the conventional pulmonary
inert gas elimination theory due to Farhi. On the other hand, these profiles can reliably
be captured by virtue of a previously developed mathematical model for the general
exhalation kinetics of highly soluble, blood-borne VOCs, which explicitly takes into
account airway gas exchange as major determinant of the observable breath output.
This model allows for a mechanistic analysis of various rebreathing protocols suggested
in the literature. In particular, it predicts that the end-exhaled levels of acetone
and methanol measured during free tidal breathing will underestimate the underlying
alveolar concentration by factor of up to 1.5. Moreover, it clarifies the discrepancies
between in vitro and in vivo blood-breath ratios of hydrophilic VOCs and yields further
quantitative insights into the physiological components of isothermal rebreathing and
highly soluble gas exchange in general.
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1. Introduction
Over the past decade, much advance has been made in the attempt to extract the
diagnostic and metabolic information encapsulated in a number of endogenous volatile
organic compounds (VOCs) appearing in human exhaled breath [1–3]. However, the
quantitative understanding of the relationships between breath concentrations of such
trace gases and their underlying systemic levels clearly lags behind the enormous
analytical progress in breath gas analysis. In particular, formal means for evaluating
the predictive power of various breath sampling regimes are still lacking.
Recently, several efforts have been undertaken to complement VOC measurements
with adequate physical models mapping substance-specific distribution mechanisms in
the pulmonary tract as well as in the body tissues. Some major breath VOCs have
already been investigated in this form, e.g., during rest and exercise conditions or
exposure scenarios [4–12]. Such mechanistic descriptions of the observable exhalation
kinetics give valuable insights into the relevance of the measured breath concentrations
with respect to the endogenous situation and hence are mandatory to fully exploit the
diagnostic potential of breath VOCs.
Within this context, the main focus of this article will be on a modeling-based
review of isothermal rebreathing, which has been proposed as an experimental tech-
nique for estimating the alveolar levels of hydrophilic exhaled trace gases [13–15]. This
class of compounds has been demonstrated to significantly interact with the water-like
mucus membrane lining the conductive airways, an effect which has become known as
wash-in/wash-out behavior. For further details we refer to [5,16]. As a phenomenologi-
cal consequence, exhaled breath concentrations of such highly water soluble substances
tend to be diminished on their way up from the deeper respiratory tract to the airway
opening. The resulting discrepancies between the “true” alveolar and the measured
breath concentration can be substantial (even if breath samples are drawn in a strictly
standardized manner employing, e.g., CO2- or flow-controlled sampling) and will depend
on a variety of factors, including airway temperature profiles and airway perfusion as
well as breathing patterns [17].
In particular, the above-mentioned effect considerably departs from the classical
Farhi description of pulmonary inert gas exchange [18], on the basis of which the op-
erational dogma has been established that end-tidal air will reflect the alveolar level
and that arterial concentrations can be assessed by simply multiplying this value with
the blood:gas partition coefficient λb:air at body temperature. This “common knowl-
edge” has first been put into question in the field of breath alcohol testing, revealing
observable blood-breath concentration ratios of ethanol during tidal breathing that are
unexpectedly high compared to the partition coefficient derived in vitro [13]. Similarly,
excretion data (i.e., the ratios between steady state partial pressures in expired air and
mixed venous blood) of highly water soluble compounds (including the MIGET test
gas acetone) have been shown to underestimate the values anticipated by treating the
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airways as an inert tube [19,20].
In a previously published mathematical model for the breath gas dynamics of highly
soluble blood-borne trace gases, airway gas exchange is taken into account by separating
the lungs into a bronchial and alveolar compartment, interacting via a diffusion barrier
mimicking pre- and post-alveolar uptake [9]. This formulation has proven its ability
to reliably capture the end-tidal breath profiles as well as the systemic dynamics of
acetone in a variety of experimental situations and will be used here for illuminating
the physiological processes underlying isothermal rebreathing tests as carried out in the
literature. For comparative reasons, the illustration in the sequel will mainly be limited
to acetone, with possible extrapolations to other highly soluble VOCs indicated where
appropriate.
2. Methods
2.1. Experiments
Extensive details regarding our experimental setup are given elsewhere [9,21,22]. Here,
we will only briefly discuss the parts relevant in the context of isothermal rebreathing.
The rebreathing system itself consists of a Tedlar bag (SKC, Dorset, UK) with
a volume of V˜bag = 3 l, that can directly be connected to a spirometer face mask
covering mouth and nose. From the latter, end-tidal exhalation segments are drawn
into a Proton Transfer Reaction Mass Spectrometer (PTR-MS; Ionicon Analytik GmbH,
Innsbruck, Austria), which allows for VOC detection and quantification on a breath-
by-breath resolution as described in [21]. The rebreathing bag is warmed to 37 ± 1◦C
by means of a specially designed outer heating bag (Infroheat Ltd., Wolverhampton,
UK), cf. [15]. Heating is intended to assist the thermal equilibration between the
alveolar tract and the upper airways and prevents condensation and subsequent losses
of hydrophilic VOCs depositing onto water droplets forming on the surface wall of the
bag. End-tidal acetone concentrations are determined by monitoring the protonated
compound at m/z = 59 (dwell time 200 ms). Additionally, we routinely measure the
mass-to-charge ratios m/z = 21 (isotopologue of the primary hydronium ions used for
normalization; dwell time 500 ms), m/z = 37 (first monohydrate cluster H3O
+(H2O)
for estimating sample humidity; dwell time 2 ms), m/z = 69 (protonated isoprene;
dwell time 200 ms), m/z = 33 (protonated methanol; dwell time 200 ms) as well as
the parasitic precursor ions NH+4 and O
+
2 at m/z = 18 and m/z = 32, respectively,
with dwell times of 10 ms each. In particular, following [15], the pseudo concentrations
associated with m/z = 32 determined according to standard PTR-MS practice (see,
e.g., [23, Eq. (1)]) will be used as a surrogate for the end-tidal oxygen partial pressure
PO2 (relative to an assumed nominal level at rest of 100 mmHg). Similarly, calibrated
pseudo concentrations corresponding to m/z = 37 are considered as an indicator for
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absolute sample humidity Cwater, see [9] for further details. Partial pressures PCO2 of
carbon dioxide are obtained via a separate sensor. Table 1 summarizes the measured
quantities used in this paper. In general, breath concentrations will always refer to
end-tidal levels.
Variable Symbol Nominal value (units)
Acetone concentration Cmeasured 1 (µg/l) [24]
CO2 partial pressure PCO2 40 (mmHg) [25]
Water content Cwater 4.7 (%) [26]
O2 partial pressure PO2 100 (mmHg) [25]
Table 1. Summary of measured breath parameters together with some nominal values
in end-exhaled air during tidal breathing at rest.
In total, five normal healthy male volunteers (age range 26-55 years, median 35
years) were recruited and gave written consent to participate in a single cycle rebreathing
protocol as described in section 3.2. All phenomenological results were obtained in
conformity with the Declaration of Helsinki and with approval by the Ethics Commission
of Innsbruck Medical University.
2.2. Physiological model
A schematic sketch of the model structure is presented in figure 1. For the associated
compartmental mass balance equations and the underlying model assumptions we refer
to section Appendix A as well as to the original publication [9]. Briefly, the body
is divided into four distinct functional units, for which the underlying concentration
dynamics of the VOC under scrutiny will be taken into account: bronchial/mucosal
compartment (Cbro; gas exchange), alveolar/end-capillary compartment (CA; gas
exchange), liver (Cliv; endogenous production and metabolism) and tissue (Ctis; storage).
The nomenclature is detailed in table A1.
The measurement process is described by
Cmeasured = Cbro, (1)
i.e., we assume that the measured (end-tidal) VOC concentration reflects the bronchial
level. Dashed boundaries indicate a diffusion equilibrium, described by the appropriate
partition coefficients λ, e.g., λb:air. The nomenclature is detailed in table A1.
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Figure 1. Sketch of the model structure used for capturing dynamic VOC
concentrations (C). Subscripts connote as follows: bag–rebreathing bag ; I–inhaled ;
bro–bronchial ; muc–mucosal ; A–alveolar ; c′–end-capillary ; liv–liver ; tis–tissue; b–
blood. The conductance parameter D reflects the net gas exchange between the
bronchial and the alveolar tract over a complete respiratory cycle as described in
the text. Note that D is close to zero during free tidal breathing at rest (i.e., the
measurable breath acetone levels are almost exclusively determined by the respective
levels in the conducting airways) and varies in parallel with ventilatory flow, cf. (5).
In particular, higher values of D correspond to an increased contribution of the alveoli
to total pulmonary gas exchange.
In particular, during tidal breathing at rest the present model replaces the
familiar Farhi equation describing the steady state relationship between inhaled
(ambient) concentration CI, measured breath concentrations C
F
measured, mixed venous
concentrations Cv¯ and arterial concentrations Ca during tidal breathing (cf. [18]),
CFmeasured = CA =
V˙A
Q˙c
CI + Cv¯
λb:air +
V˙A
Q˙c
=
Ca
λb:air
, (2)
with the expression (cf. [9, Eq. (21)])
Cmeasured = Cbro =
rbroCI + (1− qbro)Cv¯
(1− qbro)z(T¯ )λb:air + rbro =
rbroCI + Ca
z(T¯ )λb:air + rbro
. (3)
Here, qbro ≈ 0.01 is an estimate of the effective fractional bronchial perfusion (which
might be substance-specific), while rbro = V˙A/(qbroQ˙c) denotes the associated bronchial
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ventilation-perfusion ratio. Note that (3) is only valid for highly water- and blood-
soluble compounds such as acetone.
The term z(T¯ )λb:air reflects an explicit temperature dependence of airway gas
exchange that has been incorporated into the model. More specifically, the factor
z captures the change of VOC solubility in the airway mucosa and bronchial blood
in response to fluctuations of the characteristic mean airway and bronchial blood
temperature T¯ (in ◦C). In [9, Eqs. (3)-(5)] the latter has been shown to be estimable by
virtue of the measured sample humidity Cwater and typically ranges around 34
◦C during
tidal breathing of room air at rest. It is assumed that the temperature dependence of
λb:air is proportional to the temperature change of the mucosa:air partition coefficient
λmuc:air over the temperature range considered, i.e. z is given by
z(T¯ ) := λmuc:air(T¯ )/λmuc:air(37
◦C). (4)
Note that z decreases with increasing temperature and takes values greater than one
for T¯ below body temperature.
A particular convenience of the above representation stems from the fact that, as
a first approximation, the mucosa layer can be assumed to inherit the physico-chemical
properties of water. Correspondingly, λmuc:air can be estimated via the respective wa-
ter:air partition coefficient, which is usually available from the literature (see, e.g., the
extensive compendium in [27]).
A direct implication of the wash-in/wash-out mechanisms discussed in the
introduction is that during free tidal breathing at rest the amount of hydrophilic VOCs
reaching the alveolar region with each inhalation will be approximately equal to the
amount extracted with each exhalation. In other words, under these circumstances the
bronchio-alveolar net exchange of such compounds over one breath cycle will be close
to zero and a major part of the overall pulmonary gas exchange (e.g., up to 96% as in
the case of acetone [16]) can be ascribed to the conducting airways. As a consequence,
a concentration gradient develops along the respiratory tree, with higher levels of the
respective VOC found in the proximal (alveolar) parts. Increasing ventilatory flow
rates and volume minimizes equilibration times with the more distal mucus layers and
hence counteracts the saturation and depletion of the air stream during inhalation and
exhalation, respectively. Consequently, the location of gas exchange is continuously
shifted towards the alveolar region and the contribution of the latter becomes more
pronounced. In particular, the end-exhaled (measured) breath concentration approaches
values closer to the alveolar level.
Formally, this rationale can be incorporated into the model by including a diffusion
term of the form D(Cbro − CA) into the underlying mass balance equations, cf. [9].
This expression reflects the above-mentioned net gas exchange between the alveolar and
the bronchial tract over a complete breath cycle. From the previous paragraph the
conductance parameter D will be close to zero during free tidal breathing at rest and
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increases with ventilatory flow, viz.,
D := kdiff,1 max{0, VT − V restT }+ kdiff,2 max{0, V˙A − V˙ restA }, (5)
where V˙A and VT denote alveolar ventilation and tidal volume, respectively. The positive
coefficients kdiff,i can be estimated from experimental data, see [9] and table A1.
A primary advantage of the above treatment is that much of the temporal and
spatial heterogeneity associated with highly soluble gas exchange can be captured
within a unidirectional rather than a bidirectional flow framework as in [4, 5]. From
an operational view, this drastically reduces the number of required model equations,
thereby yielding parsimonious parameterizations as well as tractable model structures.
3. Results and discussion
3.1. Heuristic considerations
As has already been indicated in the introduction, (2) is inappropriate for capturing
experimentally obtained arterial blood-breath concentration ratios (BBR) of highly
water soluble trace gases during free breathing at rest (i.e., assuming CI = 0). For
instance, in the specific case of acetone, multiplying the proposed end-tidal population
mean of approximately 1 µg/l [24] with a blood:gas partition coefficient of λb:air =
340 [16] at body temperature appears to grossly underestimate arterial blood levels
spreading around 1 mg/l [28, 29]. In contrast, (3) asserts that the observable arterial
blood-breath ratio in this case is
BBR =
Ca
Cmeasured
= z(T¯ )λb:air + rbro, (6)
and will thus depend on airway temperature and airway blood flow as mentioned in
the previous section. In particular, note that the BBR will be greater than the in vitro
blood:gas partition coefficient λb:air for T¯ below body temperature, cf. (4).
From (6) it is clear that the more soluble a VOC under scrutiny, the more drastically
its observable BBR will be affected by the current airway temperature, with an inverse
relation between these two quantities. This deduction is consistent with measurements
by [14] conducted in the field of alcohol breath tests, reporting a monotonous decrease
of ethanol BBR values with increasing exhaled breath temperature. In the same
contribution, BBRs of ethanol during normal tidal breathing were shown to typically
exceed a value of 2500, which differs from the expected value λb:air = 1756 by more than
40%. For comparison, based on a mean characteristic airway temperature of about
T¯ = 34◦C [30] and the water:air partition coefficient λmuc:air provided by [27, p. 568], by
substituting the parameter values in table A1 we find that (6) predicts an experimentally
observable blood-breath ratio of ethanol in the range of 2250. Equation (6) also suggests
that in the case of VOCs with an extremely high affinity for both blood and water (e.g.,
ethanol, methanol), the discrepancies between in vivo and in vitro BBR values might
largely be removed by warming the airways to body temperature before the breath
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sampling procedure. Contrarily, blood-breath ratios of less soluble VOCs, e.g., acetone,
will additionally be affected by the comparatively large value of rbro.
Apart from providing some experimental evidence for the validity of (6), these ad
hoc calculations suggest that the common practice of multiplying the measured breath
concentration Cmeasured with λb:air to obtain arterial concentrations for highly soluble
trace gases will result in an estimation that might drastically differ from the true blood
level.
Isothermal rebreathing has been put forward as a valuable method for removing
the above-mentioned discrepancies. The heuristic intention leading to isothermal
rebreathing is to create an experimental situation where the breath levels of highly
soluble VOCs are not altered during exhalation due to loss of such substances to the
cooler mucus layer of the airways. This can be accomplished by “closing the respiratory
loop”, i.e., by continuous re-inspiration and -expiration of a fixed mass of air‡ from a
rebreathing receptacle (e.g., a Tedlar bag), causing the airstream to equilibrate with
the mucosa linings over the entire respiratory cycle [14–16]. Additionally, warming the
rebreathing volume to body temperature will ensure a similar solubility of these VOCs
in both regions, alveoli and airways.
Formally, a model capturing the experimental situation during isothermal rebreath-
ing can simply be derived by augmenting the model equations in section Appendix A
with an additional compartment representing the rebreathing receptacle, i.e.,
dCbag
dt
V˜bag = V˙A(Cbro − Cbag) (7)
and by setting CI = Cbag in (A.1). In the sequel, we will furthermore assume
that the (mixed) venous blood concentrations stay roughly constant throughout the
rebreathing periods investigated in the present context. This can be seen as a necessary
physiological requirement backed by the fact that both blood and most body tissues have
an enormous storage capacity with respect to hydrophilic compounds, implying that the
corresponding concentrations within these compartments will vary extremely slowly in
response to a change in inhaled concentration levels. Consequently, we may conclude
that if the conducting airways are warmed to body temperature during rebreathing
(i.e., if z(T¯ ) in (4) approaches unity as temperature increases) the compartmental
concentrations in the pulmonary tract will tend to a new quasi steady state§ obeying
Crebrmeasured = C
rebr
bro = C
rebr
bag = C
rebr
A =
Crebra
λb:air
=
Cv¯
λb:air
. (8)
‡ For the sake of completeness, it should be noted that a small part of the air within the rebreathing
circuit outlined in section 2.1 is actually consumed by the PTR-MS device (roughly 40 ml/min), which,
however, can safely be neglected in the present setting.
§ We stress the fact that this is not a steady state in the strict mathematical sense, i.e., corresponding
to a situation where all time-derivatives of the mass balance equations in section Appendix A are
exactly zero. Effectively, in a hypothetical situation where rebreathing could be continued for several
hours, breath acetone concentrations would still vary in parallel with a slow increase of body tissue and
mixed venous blood levels.
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This is a simple consequence of substituting CI with Cbro in (3) according to the quasi
equilibrium relation associated with (7). Similarly, the classical Farhi model yields
CF,rebrmeasured = C
F,rebr
bag = C
F,rebr
A =
CF,rebra
λb:air
=
Cv¯
λb:air
. (9)
It is important to realize that if such quasi steady state conditions hold they will de-
pend solely on the blood:air partition coefficient λb:air at 37
◦C, thus rendering isothermal
rebreathing as an extremely stable technique for providing a reproducible coupling be-
tween VOC levels in breath and blood. Particularly, it theoretically avoids the additional
measurement of ventilation- and perfusion-related variables that would otherwise affect
this relationship, thereby significantly simplifying the required technical setup for breath
sampling. However, as will be illustrated in the following, the major practical obstacle
is to guarantee that a quasi steady state as in (8) is effectively attained.
For the purpose of comparing the qualitative implications of (2) and (3) it
is instructive to note that the corresponding ratios between measured rebreathing
concentrations and end-exhaled concentrations during free tidal breathing at rest will
follow an entirely different trend. To this end, note that while from (9) and by setting
CI = 0 in (2) we find that
CF,rebrmeasured
CFmeasured
→ Cv¯/λb:air
Cv¯/(λb:air + V˙A/Q˙c)
=
λb:air + V˙A/Q˙c
λb:air
, (10)
an analogous computation using (8) and (3) shows that
Crebrmeasured
Cmeasured
→ (1− qbro)z(T¯ )λb:air + rbro
(1− qbro)λb:air , (11)
where z(T¯ ) ≥ 1, cf. (4). For highly soluble trace gases, this observation constitutes a
simple test for assessing the adequacy of the Farhi formulation regarding its ability to
describe the corresponding exhalation kinetics. Indeed, for sufficiently large λb:air, the
right-hand side of (10) will be close to one, while the right-hand side of (11) suggests
that rebreathing will increase the associated end-tidal breath concentrations. In other
words, for this class of compounds a markedly non-constant behavior during the initial
isothermal rebreathing period indicates that (2) will fail to capture some fundamental
characteristics of pulmonary excretion. Such tests are of particular importance in the
context of endogenous MIGET methodology (Multiple Inert Gas Elimination Technique,
based on endogenous rather than externally administered VOCs [20]), as they might be
used for detecting deviations of the employed gases from the underlying Farhi description
(see also [22]).
3.2. Single cycle rebreathing
In this section we will discuss some simulations and preliminary experiments conducted
in order to study the predictive value of isothermal rebreathing within a realistic setting.
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For this purpose we will first mimic isothermal rebreathing as it has been carried out
by various investigators [13,14].
More precisely, rebreathing was instituted after tstart = 2 min of free tidal breathing
at rest by inhaling to total lung capacity and exhaling until the bag was filled, thereby
providing an initial bag concentration which can be assumed to resemble the normal
end-exhaled level, i.e.,
Cbag(0) = Cbro(0). (12)
Rebreathing was then continued until either the individual breathing limit was reached
or the CO2 partial pressure increased above 55 mmHg. The volume of the rebreathing
bag was V˜bag = 3 l according to section 2.1.
Typical profiles of end-tidal acetone, water, CO2 and oxygen content during normal
breathing and isothermal rebreathing at rest are shown in figure 2. These representative
data correspond to one single healthy male volunteer from the study cohort described
in section 2.1. An overview of the experimental outcome for all volunteers is given
in figure 3.
As has been explained above, PO2 can be derived by scaling the end-tidal level of
the PTR-MS pseudo concentration signal at m/z = 32 to a basal value of 100 mmHg
during free tidal breathing. Furthermore, breathing frequency f and tidal volume VT
may be simulated on the basis of the monitored values for PCO2 and PO2 . Under iso-oxic
conditions, after a certain threshold value is exceeded, both frequency and tidal volume
are known to increase linearly with alveolar PCO2 . Moreover, the corresponding slopes
(reflecting the chemoreflex sensitivity of breathing) are dependent on the current alveolar
oxygen partial pressure [25,31]. More specifically, hypoxia during rebreathing enhances
chemoreflex sensitivity, yielding a hyperbolic relation between the mentioned slopes
and PO2 . These findings result in a simple model capturing the chemoreflex control of
breathing in humans [32], which has been re-implemented in order to compute f and VT
from basal values during free breathing, cf. figure 2. Here, for simplicity it is assumed
that end-tidal PCO2 levels reflect those of the peripheral and central chemoreceptor
environment. The ventilation rate follows from
V˙A = f(VT − VD), (13)
using an instrument (mask) deadspace volume of VD = 0.1 l.
Since cardiac output can be expected to stay relatively constant during the
rebreathing phase [15], we fix its value at a nominal level of 6 l/min. Using the
parameter values in table A1 for a male of height 180 cm and weight 70 kg this completes
the necessary data for simulating the above-mentioned rebreathing experiment. More
specifically, the model response in the first panel of figure 2 is obtained by integrating
the differential equations (A.1)–(A.4) and (7), setting CI = Cbag for t ∈ [tstart, tend]
and CI ≡ 0 otherwise. The initial concentrations for each compartment as well as the
underlying endogenous acetone production rate kpr = 0.055 mg/min for this specific
experiment are derived from the algebraic steady state conditions at t = 0.
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Figure 2. Representative outcome of an isothermal rebreathing experiment during
rest. Data correspond to one single normal healthy male volunteer from the study
cohort in section 2.1 (Volunteer 1, see also figure 3). Isothermal rebreathing starts
at tstart = 2 min and ends at approximately tend = 4.6 min. Measured or derived
quantities according to the experimental setup are shown in the first and third panel
(red tracings), while data in the second and fourth panel correspond to simulated
variables as described in the text (black tracings).
From figure 2, the proposed model is found to faithfully reproduce the observed
data. Further improvement of the goodness-of-fit might be achieved by employing
parameter estimation techniques as described, e.g., in [8, 9] which, however, would be
beyond the scope of this paper.
In contrast, as can be anticipated from (10), when using the classical Farhi
formulation for gas exchange in the the pulmonary tract (i.e., when treating the
conducting airways as an inert tube) the given breath acetone profile cannot be
captured‖.
In particular, the presented data appear to consolidate the heuristic considerations
in section 3.1 and confirm that the alveolar concentration of acetone during free tidal
breathing can differ from the associated bronchial (i.e., measured end-exhaled) level
by a factor of more than 1.5. As has been explained in section 2.2, this is due to an
‖ Considering the fact that the Farhi formulation is included in the present model as a limiting case
for qbro = 0 and D → ∞ [9, Fig. 4], its associated output can be computed in a similar manner as
described above.
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effective concentration gradient between the conducting airways and the alveolar space.
During isothermal rebreathing, this gradient slowly vanishes and causes the measured
breath concentration to approach the underlying alveolar concentration. It should be
noted that the latter as well as the simulated levels in liver and storage tissue stay
almost constant throughout this period, which is consistent with the quasi steady state
assumption made in (8). We also stress the fact that in order to simulate a similar breath
profile by using the conventional Farhi formulation (i.e., by treating the airways as an
inert tube), one essentially would have to postulate a temporarily increased endogenous
acetone production during rebreathing, which, however, lacks physiological plausibility.
For comparative reasons, in figure 2 and figure 3 we also display the simultaneously
obtained PTR-MS concentration profiles of breath methanol, scaled to match the initial
levels of breath acetone. Taking into account a methanol blood:gas partition coefficient
of λb:air = 2590 at body temperature [4], from (11) it can be deduced that for this
compound the differences between concentrations extracted during free breathing and
rebreathing primarily stem from the thermal equilibration between airways and alveolar
tract. The corresponding rise in temperature is mirrored by a steady increase of sample
water vapor Cwater, approaching an alveolar level of about 6.2%. In particular, the
presented profiles for methanol show the necessity of including an explicit temperature
dependence in models describing the rebreathing behavior of highly soluble VOCs.
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Figure 3. Breath acetone/methanol profiles during isothermal rebreathing for all five
volunteers in the study cohort. Breath methanol profiles were scaled to match the
initial levels of breath acetone. Rebreathing starts at tstart = 2 min. As soon as the
individual breathing limit is reached (roughly between 4 and 5 min), the volunteers
disconnect the rebreathing bag and continue with free tidal breathing at rest.
As a last point in this section, we would like to emphasize the fact that all model
parameters and initial conditions pi governing the simulation in figure 2 can be ranked
with respect to their impact on the observable breath acetone concentration during
the isothermal rebreathing period [tstart, tend] by numerically approximating the squared
L2-norm of the corresponding normalized sensitivities, viz.,
ς(pi) :=
tend∫
tstart
(
∂Cmeasured(t)
∂pi
pi
maxs |y(s)|
)2
dt. (14)
Adopting the nomenclature in section Appendix A, these indices were calculated for
all effective compartment volumes, partition coefficients, initial concentrations, and
for pi ∈ {kpr, kmet, qbro, kdiff,1, kdiff,2}. Among these, the decisive quantities are the
blood:gas partition coefficient (negative influence; ς(λb:air) = 2.07) as well as the initial
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concentrations and partition coefficients for the liver and tissue compartment (positive
influence; ς(Cliv(0)) = 0.06; ς(λb:liv) = 0.06; ς(Ctis(0)) = 1.39; ς(λb:tis) = 1.39). In
particular, the latter essentially define the mixed venous blood acetone concentration
Cv¯ according to (A.5). As this concentration stays almost constant throughout the
entire experiment, the above sensitivity analysis results are in direct agreement with (8),
predicting a rebreathing plateau that exclusively depends on λb:air and Cv¯. All other
sensitivity indices take values below 0.015.
3.3. Sequential rebreathing
On the basis of the results from the previous subsection, in the following we will briefly
discuss a sequential rebreathing protocol developed by [15]. This regime aims at improv-
ing the patient compliance of conventional rebreathing by repeatedly providing cycles of
five rebreaths (postulated to last approximately 0.5 min) with intermediate periods of
free tidal breathing lasting approximately 10 min. According to above-mentioned pro-
tocol, isothermal rebreathing is again instituted by inhaling to total lung capacity and
exhaling to residual volume into a Tedlar bag with a volume of V˜bag = 3 l. After each
rebreathing cycle, the bag is closed, a small amount of bag air (< 100 ml) is measured
and the volunteer starts the next cycle by exhaling to residual volume and inhaling from
the bag.
From the data in the last two panels of figure 2 it can be inferred that all
physiological input variables will have returned to pre-rebreathing values within the
10 min breaks. For simulation purposes, it will hence be assumed that their behavior
during repeated rebreathing segments is identical to the profiles within the first 0.5 min
of single cycle rebreathing. Values for the initial compartment concentrations as well as
for the additional parameters are adopted from the previous subsection. These premises
allow for simulating the evolution of breath acetone within a repeated rebreathing
regime as displayed in figure 4. Here, the initial bag concentration at the onset of
each individual rebreathing cycle is determined by the final bag concentration after the
preceding rebreathing cycle, i.e., no fresh room air enters the bag.
The bag concentration profile in figure 4 qualitatively resembles the data presented
by [15]. However, what emerges from this modeling-based analysis is that in spite
of steadily increasing bag concentrations (finally reaching a plateau level), the latter
might not necessarily approach the underlying alveolar concentration as in the case
of single cycle rebreathing. The major reason for this is a lack of complete thermal
and diffusional equilibration between the airways and the alveolar region within the
individual rebreathing segments. One potential way to circumvent this issue would
be to reduce the desaturation and cooling of the airway tissues between consecutive
rebreathing segments by keeping the intermediate time interval of free tidal breathing
as short as possible (while simultaneously maintaining a regime allowing for comfortable
breathing).
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The second panel in figure 4 displays the evolution of the predicted blood-bag
concentration ratios during the course of experimentation. Note that the in vitro
blood:gas partition coefficient λb:air = 340 is never attained. This observation can offer
some explanation for the discrepancies that continue to exist with regard to theoretical
and experimentally measured ratios between blood and (rebreathed) breath levels [33].
Furthermore, the final plateau value and the observable BBR of acetone will vary with
temperature (cf. (6)), which is consistent with similar observations made in the case of
breath ethanol measurements [14].
Figure 4. Simulation of a sequential rebreathing protocol according to [15] with
intermediate pauses of 10 min characterized by free tidal breathing. The underlying
model parameters correspond to the individual fit in figure 2. Dash-dotted lines
represent upper and lower bounds for the bag concentration as well as for the observable
blood-bag ratio with respect to changes in airway temperature T¯ . These bounds were
obtained by assuming that the airway temperature either instantaneously rises to body
core temperature during the individual rebreathing periods or remains constant (i.e.,
at its initial level T¯0) throughout the entire experiment.
4. Conclusions
Here we have successfully applied a previously published compartment model for the
exhalation kinetics of highly soluble, blood-borne VOCs to the experimental framework
of isothermal rebreathing. The proposed model has proven sufficiently flexible for cap-
turing the corresponding end-tidal breath dynamics of acetone, which can be viewed
A modeling-based evaluation of isothermal rebreathing 16
as a prototypical test compound within this context. Moreover, it allows for a quan-
titative assessment of the discrepancies between in vitro and measured blood-breath
ratios of such VOCs during the cyclical steady state observed in normal tidal breathing
and can serve as a relatively simple mechanistic basis for describing some fundamental
physiological processes associated with the observable VOC behavior in response to the
above-mentioned experimental regime.
Several practical implications emerge from this modeling-based analysis. Firstly, it
is demonstrated that the classical Farhi setting will fail to reproduce the experimentally
measured acetone exhalation data during isothermal rebreathing if a constant
endogenous production and metabolism rate is postulated. This is due to the fact that
airway gas exchange, being a major determinant affecting the breath levels of highly
soluble VOCs, is not taken into account within this formalism. Furthermore, multiplying
end-tidal breath concentrations during free tidal breathing with the substance-specific
blood:gas partition coefficient λb:air will generally underestimate the true arterial blood
concentration for highly blood and water soluble VOCs.
Excessive hypoxia and hypercapnia are the main factors limiting the duration
of the rebreathing maneuver and preventing a complete equilibration of VOC partial
pressures in the alveoli and the conducting airways. From an operational point of view,
our data indicate that even if isothermal rebreathing is continued until the individual
breathing limit is reached, a quasi steady state according to (8) might not necessarily
be attained. As can be deduced from figure 2 in the case of acetone, end-exhaled breath
(or bag) concentrations extracted after about 0.5 min of rebreathing (corresponding to
the common protocol of providing around five consecutive rebreaths) are still likely to
underestimate the underlying alveolar level CA. Analogous conclusions can be drawn
for sequential rebreathing protocols designed to allow for a recovery of the volunteer
during the individual rebreathing segments.
A reliable extraction of meaningful breath levels for highly soluble VOCs by virtue of
isothermal rebreathing hence appears to require more sophisticated setups incorporating
the continuous removal of CO2 and replacement of metabolically consumed oxygen.
Provided that the influence of chemical CO2-absorption on the measured breath and
bag concentrations is negligible, such setups might for instance be adapted from closed
chamber techniques [34] or general closed-circuit anesthesia systems.
Alternatively, alveolar concentrations might be extrapolated to some extent
from partially equilibrated rebreathing samples, using numerical parameter estimation
schemes for reconstructing VOC exhalation kinetics according to a given model
structure. While further validation and data gathering needs to be carried out before
such estimates can become practically relevant, the mechanistic descriptions discussed
in this paper are intended as a first step towards achieving this goal.
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Appendix A. Model equations and nomenclature
This appendix serves to give a roughly self-contained outline of the model structure
sketched in figure 1 [9]. The time evolution of VOC concentrations is captured by taking
into account standard conservation of mass laws for the individual compartments.
Local diffusion equilibria are assumed to hold at the air-tissue, tissue-blood and
air-blood interfaces, the ratio of the corresponding concentrations being described
by the appropriate partition coefficients λ, e.g., λb:air. Unlike for low blood soluble
compounds, the amount of highly soluble gas dissolved in the local blood volume
of perfused compartments cannot generally be neglected, as it might significantly
increase the corresponding compartmental capacities. This is particularly true for
the airspace compartments. We hence use the effective compartment volumes V˜bro :=
Vbro + Vmucλmuc:air, V˜A := VA + Vc′λb:air, V˜liv := Vliv + Vliv,bλb:liv as well as V˜tis := Vtis and
neglect blood volumes only for the mucosal and tissue compartment.
Values for the individual compartment volumes, temperature-dependent partition
coefficients, and physiological variables such as cardiac output (Q˙c) and alveolar
ventilation (V˙A) are given in table A1. Fractional blood flows to the bronchial tract (qbro)
and the liver (qliv) as well as the endogenous production (kpr) and metabolic elimination
rates (kmet) are treated as constants in the context of isothermal rebreathing.
According to figure 1, the mass balance equation for the bronchial compartment
reads
dCbro
dt
V˜bro = V˙A(CI−Cbro)+D(CA−Cbro)+qbroQ˙c(Ca−z(T¯ )λb:airCbro), (A.1)
where CI denotes the inhaled (ambient/bag) gas concentration. Similarly, for the
alveolar, liver and tissue compartment we find that
dCA
dt
V˜A = D(Cbro − CA) + (1− qbro)Q˙c(Cv¯ − λb:airCA), (A.2)
and
dCliv
dt
V˜liv = kpr − kmetλb:livCliv + qliv(1− qbro)Q˙c(Ca − λb:livCliv), (A.3)
and
dCtis
dt
V˜tis = (1− qliv)(1− qbro)Q˙c(Ca − λb:tisCtis), (A.4)
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respectively. Here,
Cv¯ := qlivλb:livCliv + (1− qliv)λb:tisCtis (A.5)
and
Ca := (1− qbro)λb:airCA + qbroz(T¯ )λb:airCbro (A.6)
are the associated concentrations in mixed venous and arterial blood, respectively.
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Parameter Symbol Nominal value (units)
Compartment volumes
Bronchioles Vbro 0.1 (l)
a
Mucosa Vmuc 0.005 (l)
a
Alveoli VA 4.1 (l)
a
End-capillary Vc′ 0.15 (l)
b
Liver Vliv 0.0285 LBV (l)
a
Blood liver Vliv,b 1.1 (l)
c
Tissue Vtis 0.7036 LBV (l)
a
Rebreathing bag V˜bag 3 (l)
a
Respiratory parameters
Breathing frequency f 12.5 (tides/min)d
Tidal volume VT 0.593 (l)
d
Alveolar ventilation V˙A 6.2 (l/min)
e
Blood flows
Cardiac output Q˙c 6 (l/min)
f
Fractional flow bronchioles qbro 0.01
g
Fractional flow liver qliv 0.32
a
Partition coefficients (37◦C)
Blood:air λb:air 340
h
Mucosa:air λmuc:air 392
i,j
Blood:liver λb:liv 1.73
j
Blood:tissue λb:tis 1.38
h
Metabolic and diffusion constants
Linear metabolic rate kmet 0.0074 (l/kg
0.75/min)l
Endogenous production kpr 0.19 (mg/min)
l
Stratified conductance D 0 (l/min)l
Constant (5) kdiff,1 14.9 (min
−1)l
Constant (5) kdiff,2 0.76
l
Table A1. Basic model parameters and nominal values during rest. LBV denotes the
lean body volume in liters calculated according to LBV = −16.24 + 0.22 bh + 0.42 bw,
with body height (bh) and weight (bw) given in cm and kg, respectively [6]; a [6];
b [35]; c [36]; d [32]; ecf. (13); f [37]; g [25]; h [16]; i [27]; j [38]; l [9].
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